CompletedNot Applicable

Anxiety and Depression in Adolescent PCOS

Turkey (Türkiye)42 participantsStarted 2025-08-17

Plain-language summary

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in adolescent females, often accompanied by psychological symptoms such as anxiety and depression. These conditions are frequently underdiagnosed and untreated. This study aims to determine the prevalence of anxiety and depression in adolescents with PCOS and to assess changes following oral contraceptive use.

Who can participate

Age range15 Years – 19 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 15 and 19 years * Diagnosis of adolescent polycystic ovary syndrome (PCOS) Exclusion Criteria: * Severe reading or comprehension difficulties * Severe hearing impairment * Current use of hormone therapy * Presence of a virilizing tumor * Major psychiatric disorders such as schizophrenia, bipolar disorder, or dissociative disorder

What they're measuring

Change in Beck Depression Inventory

Timeframe: 6 Months

Trial details

NCT IDNCT07127458

SponsorEge University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-17

View on ClinicalTrials.gov More PCOS (Polycystic Ovary Syndrome) trials